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Biodegradable polymer nanoparticles are promising carriers for targeted drug delivery in nanomedicine 
applications. Molecu- lar imprinting is a potential strategy to target polymer nanoparticles through 
binding of endogenous ligands that may promote recognition and active transport into specific cells 
and tissues. However, the lock-and-key mechanism of molecular imprinting requires relatively rigid 
cross-linked structures, unlike those of many biodegradable polymers. To date, no fully biodegradable 
molecularly imprinted particles have been reported in the literature. This paper reports the synthesis 
of a novel molecularly- imprinted nanocarrier, based on poly(lactide-co-glycolide) (PLGA) and acrylic 
acid, that combines biodegradability and molec- ular recognition properties. A novel three-arm 
biodegradable cross-linker was synthesized by ring-opening polymerization of glycolide and lactide 
initiated by glycerol. The resulting macromer was functionalized by introduction of end-functions 
through reaction with acryloyl chloride. Macromer and acrylic acid were used for the synthesis of 
narrowly-dispersed nanoparticles by radical polymerization in diluted conditions in the presence of 
biotin as template molecule. The binding capacity of the imprinted nanoparticles towards biotin and 
biotinylated bovine serum albumin was twentyfold that of non-imprinted nanoparti- cles. Degradation 
rates and functional performances were assessed in in vitro tests and cell cultures, demonstrating 
effective biotin-mediated cell internalization.
Molecular Imprinting (MI) is a technique that endows a polymeric material with “molecular memory”1 by 
cross-linking functional monomers around a template molecule. Upon polymerization and removal of the 
template, binding sites complementary to the ligand2 in size, shape and chemical properties remain imprinted 
in the rigid polymer, thus enabling recognition and selective binding. While the use of MI in separation pro-
cesses is widespread, applications in other fields, such as in targeted drug delivery, are still limited. Typically, 
target-recognition properties are built into nanoparticles by conjugation with targeting units, e.g. peptides deco-
rating the surface of the nanoparticles. However, rapid enzymatic degradation of the targeting moieties in the bio-
logical milieu can strongly reduce the efficacy of this approach. Thus, completely synthetic Molecularly Imprinted 
Particles (MIPs), able to recognize and bind endogenous ligands, would be very attractive for applications in 
targeted drug delivery. This method does not require functionalization of the nanoparticles with a targeting unit, 
as molecularly imprinted sites enable the selective binding of the endogenous ligand, thus generating the desired 
functionality. Moreover, MIPs may promote active transport into specific tissues and cell types exploiting natu-
ral mechanism of cellular uptake and providing highly specific targeted drug delivery systems3–9. Despite their 
potential, the development of MIPs as carriers for drug delivery is still in its infancy10 and the simultaneous 
optimization of biocompatibility, delivery kinetics and molecular recognition properties remains a challenge11–14.
In the last few years, biodegradable polymers have attracted considerable interest for applications to drug 
delivery, owing to their biocompatibility and control of drug release. Indeed, biodegradation of polymeric com-
ponents may prevent accumulation of the nanoparticles in organs and tissues, thus improving the safety profile 
of the material, while enabling fine control of release kinetics. To the best of our knowledge, to date, there is no 
proven synthetic strategy to obtain biodegradable MIPs with controlled size and shape. The literature reports very 
few studies on the preparation of biodegradable MI membranes15–17, or core/shell particles with biodegradable 
core and a stable imprinted shell18. However, practical demonstrations of targeted, fully biodegradable MIPs are 
still lacking. This reflects the difficulty to develop biodegradable materials with a sufficiently rigid cross-linked 
structure like that needed for the “lock and key” mechanism.
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Here, we report the synthesis and characterisation of a novel PLGA-based biodegradable MIP system. 
Through the polymerisation of a three-arm acryloyl-terminated PLGA-based crosslinker, nanoparticles were 
imprinted toward biotin, an endogenous vitamin that induces receptor-mediated endocytosis. Three reactive 
sites per cross-linker molecule conferred sufficient stiffness to the nanoparticle structure for the imprinting, while 
ester bonds of PLGA segments ensured biodegradability. This study shows the first example of the application of 
the MI technology to full biodegradable nanoparticles.
Results and Discussion
Biodegradable cross-linker, synthesis and characterization. Starting from lactide (LA) and glycolide 
(GA) as monomers, and glycerol as initiator of the Ring-Opening Polymerization (ROP), the three-arm backbone 
of the biodegradable cross-linker was prepared. End-chain functionalization with acryloyl chloride introduced 
functional groups that, after radical reaction, gave cross-linked MIPs. Detailed synthesis procedures are reported 
in the Methods section. GPC analysis confirmed the desired molecular weight (8 kDa, Supplementary Fig. S1a), 
and provided a non-linear Mark-Houwink plot (Supplementary Fig. S1b), typical for nonlinear macromolecules, 
confirming that ROP is effective also in branched polyesters. The molar composition of PLGA chains was eval-
uated from 1H-NMR spectra (Supplementary Fig. S2a), and the resulting LA/GA molar ratio was 49/51, close 
to the fixed theoretical value (50/50). 13C-NMR (Supplementary Fig. S2b) and FTIR (Supplementary Fig. S1c) 
confirmed the molecular structure and the end-chain functionalization with acryloyl chloride.
MIPs, synthesis and morphological and chemicophysical characterization. MIPs and Control 
Nanoparticles (CPs) were prepared following the procedure described in Methods section. In the radical reaction, 
we added a small amount of acrylic acid that ensured the presence of additional functional groups in the final 
product, enabling conjugation with a fluorescent dye. Synthesis was performed in diluted conditions and without 
additional surfactants, obtaining monodispersed and spherical nanoparticles (Fig. 1 and Table 1).
As template, we selected biotin, a small molecule that can induce efficient receptor-mediated endocytosis19; 
moreover, growing evidence suggests a role for this compound in cell signalling, gene expression, and chromatin 
remodeling, together with its potential involvement in cancer cell proliferation20. Molecular imprinting with bio-
tin did not affect the process of nanoparticle nucleation and growth in solution, a we found no evidence of change 
in shape, size or aggregation compared to control particles (CPs).
The comparison of FTIR spectra of MIPs nanoparticles, before and after template extraction (Fig. 2a), demon-
strated the efficacy of the template-removal procedure. In particular, the characteristic signals of the carboxylic 
and amine groups of biotin, detected between 3100 cm−1 and 3600 cm−1 (O-H and N-H stretching, broad signal) 
and at 1700 cm−1 (C = O stretching, overlapped to the signal due to carbonyl of polyester bonds) did not appear 
in the spectra from extracted nanoparticles. Moreover, the 1H-NMR spectrum (Fig. 2b) of MIPs confirmed the 
presence of both PLGA and acrylic acid in the imprinted nanoparticles and the complete extraction of the tem-
plate molecule.
Swelling tests (Fig. 2c) showed that particles dispersed in water increased their diameter in the first 40 min, as 
a consequence of water uptake. The swelling degree (see Eq. (1) in Supplementary Information) was around 0.5 
for MIPs and 0.1 for CPs at the end of the test. In particular, MIPs were more hydrophilic than CPs, due to the 
higher level of nanoporosity of MIPs resulting from the imprinting process. This hypothesis was confirmed by 
Figure 1. SEM analysis: (a) MIPs (after template extraction) (b) CPs; scalebar: 300 nm.
SEM PCS
MIPs 147.4 ± 17.4 151.9 (0.020)
CPs 131.4 ± 32.6 127.9 (0.162)
Table 1.  Mean diameters (nm) evaluated by Scanning Electron Microscopy (SEM) and Photon Correlation 
Spectroscopy (PCS) (PDI in parentheses); SEM pictures were elaborated by using the ImageJ software.
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methylene blue (MB) absorption tests: results reported in Fig. 2d and e show that the overall MIP surface area was 
2.7 times larger than that of CPs.
Recognition properties. The dissociation constant (kd) and the maximum amount of bound ligand 
([Qmax]) were estimated from the Scatchard analysis (Fig. 3a,b and Table 2). The linear trend of the Scatchard 
plot denotes the presence of one kind of binding sites, while nonlinear profiles are generally observed in MI sys-
tems, indicating the presence of binding sites with various affinities to the ligand21. Notably, MIPs showed 20-fold 
higher maximum biotin sorption capacity than CPs. Furthermore, the lower value of kd for MIPs compared to 
CPs indicates a higher stability of the biotin/nanoparticle complex formed after rebinding, thus confirming the 
effect of molecular imprinting on recognition and retention properties.
Rebinding tests with biotin-conjugated bovine serum albumin (BSAb) were also performed to assess the abil-
ity of MIPs to recognize and bind larger molecules functionalized with the template22,23. The rebinding kinetic 
profiles (Fig. 3d) demonstrated significantly higher recognition of the biotinylated albumin by MIPs than CPs 
(Table 3). The imprinting factor, defined as the ratio between the rebinding capacity of MIPs and the nonspecific 
sorption by CPs, was around 21, in line with results obtained with biotin alone.
While binding sites are also present inside the structure of MIPs, we can hypothesize that the protein was 
mainly bound by recognition sites exposed on the nanoparticle surface. Indeed, due to its size (Mw = 66 kDa24) 
and steric hindrance, albumin cannot diffuse into the polymer to reach the binding sites inside the nanoparticles.
We have evaluate the affinity distribution of binding sites at different biotin concentration, following the 
method reported by Tse Sum Bui and Haupt25. Trends of bound (B) and free (F) biotin concentrations and the 
number of binding sites N for MIPs and CPs are summarized in 4a-b. Data confirmed that binding sites populat-
ing MIPs are dependent on the association constant K, with N that ranges from 220 to 290 mol g−1 of MIPs, while 
for non-imprinted particles N is not dependent on the same parameter, with an almost constant value around 55.
The biotin sorption kinetics for MIPs and CPs, at different starting concentration of biotin and at fixed tem-
perature (37 °C) was finally evaluated. Results, summarized in Fig. 4c,d, underline the higher sorption capability 
of MIPs in comparison with CPs.
Degradation tests. Nanoparticle degradation tests were performed by PCS26,27 and GPC28. The results of 
PCS, however, were affected by the presence of nanoparticle fragments in the degradation medium and we could 
not accurately determine degradation rates. A more reliable analysis, taking into account the fractioning of nan-
oparticles, was performed by GPC.
Commonly, in the GPC analysis of nanoparticles, the apparent molecular weight is derived from a calibration 
curve obtained from standards with known molecular weights; this procedure is, in some cases, unreliable for the 
different molecular arrangement of the linear standards with respect to solid nanoparticles. Here, we have used of 
Figure 2. FTIR analysis (a) comparison between starting reactants and nanoparticles, and spectra of MIPs 
before and after template extraction; (b) 1H-NMR of extracted MIPs; (c) swelling tests by PCS; MB absorption 
tests: (d) amount of absorbed MB; (e) specific surface of nanoparticles.
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a calibration curve based on solid polystyrene nanoparticles with known diameters to overcome this limitation. 
This method allowed estimating nanoparticle diameters as a function of degradation time.
Results of degradation tests on MIPs and CPs (Fig. 5a) showed a decrease in mean diameter over time. 
In particular, the residual diameters of nanoparticles after 30 days were 54.4% and 50.3% for MIPs and CPs, 
respectively. GPC traces (Fig. 5b) showed the peak of nanoparticles at 7.5–8.0 min and an additional peak at 
late retention times, between 11 min and 12 min, indicating the presence of very small solid fragments and oli-
gomers. An estimate of apparent molecular weights of cross-linked nanoparticles was obtained by fitting the 
Mark-Houwink-Sakurada (MHS) equation to the data (Fig. 5c). Residual diameter and apparent molecular 
weight percent for MIPs are compared in Fig. 5d.
Literature reports show slower degradation kinetics for PEG-PLA nanoparticles with smaller diameter 
(residual weight 63% after one month)29 but also for nanoparticles composed of PLGA (residual weight 40%) 
or mPEG-PLGA (residual weight 60% after one week)30 of comparable diameters and under similar conditions. 
The faster degradation kinetics of our nanoparticles can be attributed to the high porosity of their structure, the 
enhanced degree of hydrophilicity, and the low molecular weight of PLGA segments.
Figure 3. (a) Scatchard analysis on a MIPs and (b) CPs nanoparticles; (c) absorbed amount of biotin at different 
starting concentrations vs maximum amount (indicated by -); (d) rebinding tests on BSAb.
MIPs CPs
kd/mol L−1 8.97 · 10−4 1.23 · 10−3
[Qmax]/mol g−1 3.14 0.20
R2 0.94 0.99
Table 2.  Dissociation constants kd and maximum amount of bound ligand per nanoparticle weight unit 
[Qmax] of MIPs and CPs systems; R2 is related to the goodness of fitting.
MIPs CPs
% BSAb retained 2.36 ± 0.80 1.01 ± 0.23
Rebinding capacity 38.06 ± 9.65 1.80 ± 0.02
Table 3.  Characteristic parameters of MIPs compared to CPs evaluated at the end of rebinding tests with 
BSAb; rebinding capacity is expressed in µmol of BSAb over g of nanoparticles.
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Figure 4. Evaluation of affinity distribution (a) bound (B) vs free (F) concentration in isothermal sorption 
tests at different starting biotin concentration (b) distribution of binding sites as a function of the association 
constant K; Sorption kinetics of biotin at 37 °C for (c) MIPs and (d) CPs nanoparticles.
Figure 5. Degradation tests by GPC data: (a) mean diameter decrease vs time; (b) chromatograms for MIPs; 
(c) apparent molecular weights of degraded nanoparticles; (d) residual % of diameter and molecular weight of 
MIPs.
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Enhanced internalization capability. The biotin recognition capabilities of our MI system make it 
a potential candidate as carrier for intracellular delivery with improved internalization properties. Since an 
over-expression of biotin receptors on the membrane of various cancer cells has been observed, MIPs against 
biotin may be exploited for selective targeting31,32. As preliminary proof-of-concept of the functional properties 
of biotin-imprinted NPs we quantified the difference in biotin-receptor binding on fluorescently labeled MIPs 
and CPs by Flow Cytometry at different time points (Fig. 6). Biotin was present in the foetal bovine serum supple-
mented in HeLa cell tissue culture. Relative fluorescence intensity of HeLa cells almost doubled after 10 minutes 
from MIPs administration compared to CPs. The difference between the two nanoparticles internalization rate 
reached a maximum in 30 minutes and was still statistically significant after 60 minutes. During the first 30 min-
utes, receptor-mediated internalization of MIPs caused a rapid and specific uptake of imprinted nanoparticles, 
while CPs were internalized by passive endocytosis. These data suggest that bound biotin was still available for 
receptor mediated cellular uptake and the complex MIPs/biotin was able to efficiently penetrate cells that over-
express biotin receptor.
Conclusions
Molecularly imprinted polymer nanoparticles have potential for the preparation of carriers for targeted drug 
delivery. Here, for the first time, the MI technology was applied to the preparation of fully biodegradable nano-
particles. The combination of biodegradation, molecular recognition and binding properties paves the way to the 
development of completely synthetic MIPs, with potentially important advantages in terms of stability, biocom-
patibility and cost of the formulation. Our results demonstrate the synthesis of imprinted nanoparticles with good 
recognition and binding properties towards biotin, alone or conjugated to moieties with larger molecular weights.
Active molecules can be loaded into our nanoparticles by physical absorption or by chemical conjugation. It 
can be foreseen that swollen structure of the nanoparticle provides a diffusive control of drug loading and release 
kinetics; furthermore, the biodegradability at longer times ensures the complete release of the payload. Due to the 
relatively fast degradation of our MIPs, the drug could be also covalently bonded and released upon hydrolysis 
of the polymer chains. While these mechanisms will be explored in future work to further develop this material, 
the present results demonstrate the feasibility of biodegradable molecular imprinted particles with recognition 
and selective binding properties; this is the first step in the exploitation of MI technology for the preparation of 
biodegradable nanoparticles for targeted drug delivery systems based on completely synthetic and biodegradable 
carriers.
Methods
Synthesis of the biodegradable crosslinker. Crude monomers lactide and glycolide monomers (LA 
and GA, Sigma Aldrich) were precipitated in ethyl acetate (Sigma Aldrich, Chromasolv® ) and exsiccated at room 
temperature under vacuum; glycerol (Gly, Sigma Aldrich) was used as as initiator and Tin(II) 2-ethylexanoate 
(Oct, Aldrich) as catalyst. Acryloyl chloride (AC, Aldrich), 4-(Dimethylamino)pyridine (DMAP, Aldrich), trieth-
ylamine (TEA, Sigma Aldrich) and dichloromethane anhydrous (DCM, Sigma Aldrich) were used for end-chain 
functionalization. Acetone, methanol and diethyl ether (Sigma Aldrich, ACS purity degree) were used as solvents.
Monomers (60 mmol of LA, 60 mmol of GA) and initiator (2 mmol of Gly, corresponding to 6 mmol of -OH 
groups) were inserted in a round-bottom single-neck glass reactor and heated at 180 °C; when temperature 
was reached, the catalyst (1.2 mmol) was added; the reactive mass was dried under N2 using a CaCl2 column. 
With this recipe, the theoretical molar ratio LA/GA of copolymer chains was 50/50 and the theoretical molec-
ular weight of the final product 8 kDa. The reactive mass was maintained at 180 °C for 3 h under mild stirring 
(100 rpm), then the reactor was quenched in a water bath, the solid product was dissolved in acetone (20 ml) and 
precipitated in methanol (50 ml) three times and finally dissolved in acetone (20 ml) and precipitated in diethyl 
ether (50 ml).
The end-chain functionalization of -OH terminal groups was performed dissolving the prepared product 
(12.5 of macromer, corresponding to 37.5 of -OH reacting groups) in DCM (20 ml) in a round-bottom two-necks 
Figure 6. Nanoparticle internalisation into Hela cells. Bar graphs represent the mean fluorescence intensity 
(MFI) of HeLa cells treated with control nanoparticles and MIP-nanoparticles; data are expressed as mean ± SE 
of at least three independent experiments; statistical significance versus controls was calculated using one-way 
ANOVA with Dunnett’s post hoc test (***p < 0.001, (****p < 0.0001).
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glass reactor together with TEA (37.5); when the solution was homogenous, AC (45.0, with a slight excess with 
respect to -OH molar concentration) was added under stirring in an ice bath for 10 min; finally, DMAP (38.0) 
was added. Reaction was maintained under stirring, at room temperature, for 8 h. At the end, the product was 
concentrated with a rotary evaporator, precipitated three times in methanol and one time in diethyl ether, and 
then exsiccated for 24 h under vacuum. Product was stored at − 20 °C in a glass vial.
Synthesis of imprinted (MIPs) and control (CPs) nanoparticles. Nanoparticle synthesis involved 
the novel-synthesized biodegradable cross-linker and acrylic acid anhydrous (AA, Aldrich, 99%). AA was puri-
fied using a glass column packed with an inhibitor remover, then stored at − 20 °C and used within one week. 
Acetonitrile (ACN, Sigma Aldrich, HPLC purity degree) and bidistilled water were used as porogen; potassium 
persulfate (KPS, Aldrich, ACS degree) was used as radical initiator, and biotin (Sigma Aldrich, > 99%) as tem-
plate molecule. The cross-linker (3.1) was dissolved in ACN (3 ml) in a glass reactor under mild stirring; AA 
(1.6) and biotin (40.9) were diluted in 0.5 ml of ACN separately and added to the reactor, then the temperature 
was increased to 70 °C; reactants and template molecule were maintained under stirring for 30 min before the 
introduction of the radical initiator, previously dissolved in 1 ml of distilled water at room temperature. An Allhin 
reflux condenser was used for the control of the reaction temperature; the reactor was flushed with N2 during the 
reaction. Control nanoparticles (CPs) were prepared with the same procedure, without the template molecule. 
Nanoparticles were purified by dialysis over water (5 h) and then over ethanol (2 h), and finally lyophilized and 
stored at − 20 °C before the use. This procedure allowed elimination of unreacted monomers and initiator, and 
also extraction of the template molecule from MIPs.
Recognition properties. Scatchard analysis was performed to evaluate equilibrium dissociation constant 












where Q is the amount of biotin retained by nanoparticles in mol g−1 and ceq is the biotin concentration in the 
test solution in mol L−1. Analysis was performed on polymer nanoparticle samples (0.25 ± 0.05 mg) immersed 
in phosphate buffered saline (PBS) solution with pH 7.4 containing biotin at different concentrations (from 
12.5 ml−1 to 200 ml−1) and maintained in a thermostatic bath at 37 °C throughout the duration of test period; after 
24 h, samples were centrifuged at 14 krpm for 1 min, and the supernatant solution was collected and analysed by 
High-Performance Liquid Chromatography (HPLC) to evaluate the residual biotin not retained by nanoparticles. 
The same test was performed on CPs as reference to evaluate the nonspecific contribution to the sorption pro-
cess. The chromatographic method used a Water chromatograph, a Luna C8 (Phenomenex) column maintained 
at 30 °C; ACN/water (50/50 v/v, isocratic, 1 ml min−1) was used as internal phase; data were collected from UV 
detector at 220 nm wavelength.
The affinity distribution was calculated with a graphical method, based on Freundlich isotherm, as reported 
in the literature25. Briefly, the trend of the concentration of bound (B) biotin as a function of free biotin (F) can be 
described with a power law:
= .B aF (2)m
Experimental data were reported in a logarithmic plot (Fig. 4a) and fitted, obtaining a and m. From a and m, 
values of N were evaluated as:
= . − .−N am m K2 3 (1 ) (3)m2





Affinity distribution, given by the trend of N with ln(K), for MIPs and CPs are summarized in Fig. 4b.
Sorption kinetics onto MIPs and CPs was evaluated with the same procedure but samples were collected and 
analyzed at 1, 2, 3, 4, 8, 16 and 24 h after the test was started. Rebinding tests were performed on both MIPs and 
CPs nanoparticles to evaluate the capability to recognize the biotin molecule after extraction. Tests were carried 
out by immersing extracted MIPs nanoparticles and CPs (1.64 ± 0.28 mg) in 0.5 ml of biotinylated bovine serum 
albumin (BSAb, Sigma) solutions (150 ml−1); samples were withdrawn at different times (from 0 to 120 min) and 
centrifuged, supernatant was collected and analysed by UV-vis spectrophotometer (V550 spectrophotometer, 
JASCO Europe); values of absorbance at 280 nm were used for quantification of BSAb re-bound by nanoparticles.
Degradation tests. Nanoparticle degradation tests were performed in triplicate maintaining samples (1 mg) 
in PBS at 37 °C for the test period. At different time points samples were collected and characterized by PCS and 
GPC. For PCS analysis, samples were inserted into plastic cuvettes and measured with a Zetasizer S90 Nano 
apparatus; for GPC analysis, samples were injected in an apparatus composed of a Shimadzu chromatograph and 
a multi-detector suite (Agilent, MDS 1260) equipped by UV detector, refractive index, viscometric detector and 
dual-angle light scattering (15° and 90°). Two columns, Aquagel-OH 40 and Aquagel-OH 30 (Agilent) were used 
for the analysis. The mobile phase was a 10% SDS solution in water; GPC measurements were performed at 40 °C.
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Enhanced internalization capability. Internalisation tests were performed with fluorescence-marked 
nanoparticles (see Supplementary Information).
Cell culture tests were performed to evaluate internalisation capabilities of MIPs compared to CPs. Cells were 
cultured in high glucose DMEM with 10% FBS, 2 mM L-glutamine, 1000 U ml−1 penicillin and 1 mg ml−1 strep-
tomycin. Cells (passage 2–20) were maintained in a humidified cell culture incubator at 37 °C and 5% CO2. 
About 24 h after being plated at 60% confluence, HeLa cells were treated with fluorescent CPs or MIPs at a final 
concentration of 2 mg ml−1. Cells were harvested after trypsinisation at 10, 30 and 60 min of incubation with nan-
oparticles, and analysed by flow cytometry using a MACSQuant analyser (Miltenyi Biotec, Bergisch Gladbach, 
Germany) for nanoparticles internalisation.
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